Search Result

Results for "

carboxypeptidase-a

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Apoptosis (2) Autophagy (2) Bcl-2 Family (2) Endogenous Metabolite (1) GLP Receptor (2) Insulin Receptor (2) Isotope-Labeled Compounds (2) p38 MAPK (2) α-synuclein (2)
By Research Areas:	Cancer (2) Metabolic Disease (2) Neurological Disease (2)

Inhibitors & Agonists

Peptides

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Targets Recommended: Carboxypeptidase

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-114118S1

Semaglutide-d8 tetraTFA	Isotope-Labeled Compounds GLP Receptor Insulin Receptor α-synuclein Apoptosis p38 MAPK Autophagy Bcl-2 Family	Neurological Disease Metabolic Disease Cancer
Semaglutide-d₈ tetraTFA is the deuterium labeled Semaglutide (HY-114118). Semaglutide is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .

HY-114118S

Semaglutide-d8	Isotope-Labeled Compounds GLP Receptor Insulin Receptor α-synuclein Apoptosis p38 MAPK Autophagy Bcl-2 Family	Neurological Disease Metabolic Disease Cancer
Semaglutide-d₈ is the deuterium labeled Semaglutide (HY-114118). Semaglutide is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .

HY-P2980

Carboxypeptidase A, Bovine pancreas EC 3.4.2.1	Endogenous Metabolite	Others
Carboxypeptidase A, Bovine pancreas (EC 3.4.2.1) is a zinc-containing metalloprotease, is often used in biochemical studies. Carboxypeptidase A catalyzes the hydrolysis of the peptide bonds that are adjacent to the C-terminal end of a polypeptide chain. Carboxypeptidase A is a prototypical enzyme for metalloproteases that plays important roles in biological systems .

HY-E71058

Human Pancreatic Carboxypeptidase A

Cat. No.	Product Name	Target	Research Area

HY-114118S1

Semaglutide-d8 tetraTFA	Isotope-Labeled Compounds GLP Receptor Insulin Receptor α-synuclein Apoptosis p38 MAPK Autophagy Bcl-2 Family	Neurological Disease Metabolic Disease Cancer
Semaglutide-d₈ tetraTFA is the deuterium labeled Semaglutide (HY-114118). Semaglutide is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .

HY-114118S

Semaglutide-d8	Isotope-Labeled Compounds GLP Receptor Insulin Receptor α-synuclein Apoptosis p38 MAPK Autophagy Bcl-2 Family	Neurological Disease Metabolic Disease Cancer
Semaglutide-d₈ is the deuterium labeled Semaglutide (HY-114118). Semaglutide is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .

Recombinant Proteins Recommended:

Carboxypeptidase A

Species:	Human (4) Rat (1) Mouse (3)
Tag:	His (8)
Source:	HEK293 (6) P. pastoris (1) E. coli (1)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P702794

	CPA3 Protein, Human (His) carboxypeptidase A; carboxypeptidase A3 (mast cell); carboxypeptidase A3; carboxypeptidase A3 mast cell; CBPA3_HUMAN; Cpa3; Mast cell carboxypeptidase A; mast cell carboxypeptidase A3; MC CPA; MC-CPA; tissue carboxypeptidase A	Human	E. coli
	CPA3 Protein, Human (His) is the recombinant human-derived CPA3, expressed by E. coli , with N-6*His labeled tag.

HY-P702795

	CPA3 Protein, Human (P.pastoris, His) carboxypeptidase A; carboxypeptidase A3 (mast cell); carboxypeptidase A3; carboxypeptidase A3 mast cell; CBPA3_HUMAN; Cpa3; Mast cell carboxypeptidase A; mast cell carboxypeptidase A3; MC CPA; MC-CPA; tissue carboxypeptidase A	Human	P. pastoris
	CPA3 Protein, Human (P.pastoris, His) is the recombinant human-derived CPA3, expressed by P. pastoris , with N-6*His labeled tag.

HY-P72868

	Carboxypeptidase A1/CPA1 Protein, Mouse (HEK293, His) carboxypeptidase A1; Cpa1	Mouse	HEK293
	Carboxypeptidase A1 (CPA1) is an enzyme responsible for catalyzing the release of a C-terminal amino acid; however, it exhibits limited or no activity with residues such as -Asp, -Glu, -Arg, -Lys, or -Pro. This specificity in substrate recognition underscores its role as a carboxypeptidase with selectivity towards certain amino acid sequences at the C-terminus of peptides. Carboxypeptidase A1/CPA1 Protein, Mouse (HEK293, His) is the recombinant mouse-derived Carboxypeptidase A1/CPA1 protein, expressed by HEK293 , with C-His labeled tag.

HY-P75452

	Carboxypeptidase A2/CPA2 Protein, Rat (HEK293, His) carboxypeptidase A2; CPA2	Rat	HEK293
	Carboxypeptidase A2/CPA2 protein is a member of the key peptidase M14 family, which plays an important role in peptide hydrolysis and contributes to the regulation of biological pathways. CPA2 may share conserved features with related proteins. Carboxypeptidase A2/CPA2 Protein, Rat (HEK293, His) is the recombinant rat-derived Carboxypeptidase A2/CPA2 protein, expressed by HEK293 , with C-His labeled tag.

HY-P7733

	Carboxypeptidase A2/CPA2 Protein, Human (HEK293, His) rHucarboxypeptidase A2, His; carboxypeptidase A2; CPA2	Human	HEK293
	Carboxypeptidase A2/CPA2 Protein, Human (HEK293, His) is an approximately 50.0 kDa human carboxypeptidase A2 with a His-flag. Carboxypeptidase A2 is a secreted pancreatic procarboxy -peptidase, and cleaves the C-terminal amide or ester bond of peptides.

HY-P7732

	Carboxypeptidase A1/CPA1 Protein, Human (HEK293, His) rHucarboxypeptidase A1, His; carboxypeptidase A1; CPA1; CPA	Human	HEK293
	Carboxypeptidase A1/CPA1 Protein, Human (HEK293, His) is an approximately 44.0 kDa human carboxypeptidase A1 protein with a His-Flag.

HY-P70078

	Carboxypeptidase A4/CPA4 Protein, Mouse (HEK293, His) rMucarboxypeptidase A4/CPA4, His; CPA4; carboxypeptidase A4	Mouse	HEK293
	Carboxypeptidase A4 (CPA4) protein is a metalloprotease associated with the histone hyperacetylation pathway, suggesting a possible involvement in epigenetic regulation. CPA4 is specific for C-terminal amino acids (such as -Phe, -Leu, -Ile, -Met, -Tyr, and -Val) and can selectively cleave substrates, suggesting a role in regulating protein composition and function. Carboxypeptidase A4/CPA4 Protein, Mouse (HEK293, His) is the recombinant mouse-derived Carboxypeptidase A4/CPA4 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P70072

	CPA2 Protein, Mouse (HEK293, His) rMucarboxypeptidase A2/CPA2, His; CPA2; carboxypeptidase A2	Mouse	HEK293
	CPA2 Protein is A member of the carboxypeptidase family that encodes zinc metalloproteinases and is expressed by pancreatic exocrine cells. CPA2 Protein acts on aromatic C-terminal residues and plays an important role in the process of degrading food to form amino acids. CPA2 Protein, Mouse (HEK293, His) is the recombinant mouse-derived CPA2 protein, expressed by HEK293 , with C-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-114118S1

Semaglutide-d8 tetraTFA
Semaglutide-d₈ tetraTFA is the deuterium labeled Semaglutide (HY-114118). Semaglutide is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .

Semaglutide-d8 tetraTFA

Semaglutide-d₈ tetraTFA is the deuterium labeled Semaglutide (HY-114118). Semaglutide is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .

HY-114118S

Semaglutide-d8
Semaglutide-d₈ is the deuterium labeled Semaglutide (HY-114118). Semaglutide is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .

Semaglutide-d8

Semaglutide-d₈ is the deuterium labeled Semaglutide (HY-114118). Semaglutide is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .

Host:	Mouse (2) Rabbit (2)
Reactivity:	Human (4) Rat (4) Mouse (4)
Application:	IHC-P (4) ICC/IF (3) WB (2) FC (2)
Isotype:	IgG (2) IgG2b (2)
Conjugation:	Non-conjugated (4)
Clonality:	Monoclonal (3) Recombinant (2)
Modification:	Unmodified (3)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P88791

	*CPA2 (Carboxypeptidase A2) Antibody (YA8475)* carboxypeptidase A2 (pancreatic)	IHC-P, ICC/IF, FC	Human, Mouse, Rat
	CPA2 (Carboxypeptidase A2) Antibody (YA8475) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to CPA2 (Carboxypeptidase A2).

HY-P87215

	Carboxypeptidase A1+A2+B Antibody (YA6903) carboxypeptidase A1 (pancreatic) antibody	WB, IHC-P	Human, Mouse, Rat
	Carboxypeptidase A1+A2+B Antibody (YA6903) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Carboxypeptidase A1+A2+B.

HY-P88791A

	*CPA2 (Carboxypeptidase A2) Antibody (YA8475)(PBS only)* carboxypeptidase A2 (pancreatic)	IHC-P, ICC/IF, FC	Human, Mouse, Rat
	CPA2 (Carboxypeptidase A2) Antibody (YA8475) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to CPA2 (Carboxypeptidase A2).

HY-P82741

	Carboxypeptidase A1/A2/B Antibody (YA2486) carboxypeptidase A1+A2+B	WB, IHC-P, ICC/IF	Human, Mouse, Rat
	Carboxypeptidase A1/A2/B Antibody (YA2486) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Carboxypeptidase A1/A2/B.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Name
Email *

	Sorry, but the email address you supplied was invalid.